-
ASB3–MAVS Ubiquitination in Antiviral Immunity
2026-09-10
The 2024 Cell Death & Differentiation study identifies ASB3 as an E3 ligase that suppresses antiviral innate immunity by promoting K48-linked ubiquitination and proteasomal degradation of MAVS. Its gain- and loss-of-function experiments connect ASB3 to reduced interferon signaling and increased susceptibility to influenza infection, providing a mechanistic framework for studying MAVS stability in infected cells.
-
KU-55933: A Translational ATM Kinase Strategy
2026-09-10
A thought-leadership perspective on using KU-55933 to connect ATM biology, DNA damage response research, cellular phenotyping, and translational decision-making without overstating preclinical evidence.
-
Streptavidin – Cy5 for USP42 Apoptosis Assays
2026-09-09
Use Streptavidin – Cy5 to convert biotinylated antibodies, probes, and detection reagents into a far-red readout for USP42, JNK/p38, and apoptosis experiments. This guide emphasizes assay architecture, flow cytometry and imaging workflows, controls, and troubleshooting rather than treating fluorescence as evidence of mechanism by itself.
-
Acridine Orange hydrochloride Protocol Guide
2026-09-09
Acridine Orange hydrochloride supports differential DNA and RNA visualization in permeable cells, making it useful for cell cycle analysis, apoptosis detection, and flow-based nucleic acid assays. It should be prepared and used promptly, with interpretation limited to nucleic acid staining rather than non-nucleic-acid targets or long-term solution storage.
-
Angiotensin Peptides and SARS-CoV-2 Receptor Binding
2026-09-09
A 2025 study reports that naturally occurring angiotensin peptides can enhance SARS-CoV-2 spike-protein binding to host receptors, with strong sequence dependence and particularly notable effects on AXL. The findings connect renin-angiotensin system peptide biology with viral receptor engagement, while remaining an in vitro binding observation rather than proof of altered infection or disease severity.
-
Moxidectin Potentiates Polyenes Against Candida albicans
2026-09-08
A 2024 study identified Moxidectin as a potentiator of amphotericin B and nystatin against Candida albicans. The work links this synergy to activation of fungal ergosterol biosynthesis, increased ergosterol abundance, and stronger polyene binding, with supportive results in a mouse oral candidiasis model.
-
Temafloxacin Workflows for Antibacterial Research
2026-09-07
Temafloxacin provides a practical bridge from broad-spectrum susceptibility screening to intracellular bacterial models, including mycobacterial assays. This guide combines concentration selection, solvent control, assay design, and a fermentation-engineering perspective to improve reproducibility without overstating translational evidence.
-
Lopinavir A8204: Reliable Antiviral Assays
2026-09-07
A scenario-driven guide to using Lopinavir (SKU A8204) in cell viability, HIV protease, and antiviral research workflows. It connects formulation data, concentration ranges, serum effects, and cell-culture evidence to practical assay design and vendor selection.
-
Red Blood Cell Lysis Buffer for Clean Blood Workflows
2026-09-05
Build cleaner mammalian blood sample preparation workflows for flow cytometry, nucleic acid extraction, protein assays, and cell culture. This guide pairs selective erythrocyte removal with practical optimization steps and a cautious translational connection to RUNX2-focused osteoblast research.
-
Cannabis Terpenes Activate A2A Receptors for Pain Relief
2026-09-04
Schwarz et al. show that five Cannabis sativa terpenes reduce pain-related behavior in mouse models of chemotherapy-induced neuropathy and inflammation, with effects linked to adenosine A2A receptor activation. Behavioral, genetic, pharmacological, biochemical, and computational experiments also suggest analgesia without conditioned reward, providing a mechanistic framework for studying terpene-based approaches to chronic pain.
-
MDV3100 and the Logic of Senescence Assays
2026-09-04
MDV3100 (Enzalutamide) is more than an androgen receptor pathway probe: it can produce a reversible senescence-like phenotype that challenges conventional assay interpretation. This guide shows how to distinguish AR inhibition, durable therapy-induced senescence, and prostate cancer apoptosis induction in research models.
-
Romidepsin (FK228) Workflow for HDAC Research
2026-09-03
Build more informative HDAC experiments with Romidepsin, from controlled chromatin perturbation to combination testing in hepatocellular carcinoma models. This workflow connects HDAC1/2 inhibition with SmD2-dependent splicing, DNA-repair phenotypes, and PARP-inhibitor sensitivity.
-
N1-Methyl-Pseudouridine-5'-Triphosphate Workflow
2026-09-03
Build more stable, translation-ready RNA for mechanistic studies and mRNA vaccine development with N1-Methyl-Pseudouridine-5'-Triphosphate. This workflow connects modified-nucleotide synthesis to a co-encapsulated antigen-and-adjuvant mRNA strategy while clearly separating established findings from experiments that still require validation.
-
BCA Protein Assay Kit for Colitis Research
2026-09-02
Translate gut-barrier and probiotic findings into reproducible protein concentration measurement with a sensitive, low-volume workflow. The BCA Protein Assay Kit supports total-protein normalization across lysates, tissue extracts, western blots, and ELISA samples while providing practical safeguards against matrix interference.
-
Podophyllotoxin: Mechanism-to-Assay Translation
2026-09-02
Podophyllotoxin is more than a microtubule inhibitor: its timing-dependent effects connect spindle disruption, cell-cycle arrest, apoptosis, and autophagy. This guide translates those mechanisms into better assay decisions while distinguishing parent compound data from podophyllotoxin-derivative findings.